Search
 
 
NIRS FLASH!

We're now lighting the way to better outcomes.

Maintaining sufficient oxygenation is critical to patient outcomes - yet numerous physiologic, environmental and treatment factors can severely effect regional oxygen saturation (rSO2) of blood in both cerebral and somatic (body) tissue.

Enter the INVOS® (pronounced in-vōs) Cerebral/Somatic Oximeter. The INVOS® System has one job: to measure changes in oxygen levels beneath the sensor in order to protect the brain and vital organ areas from hypoxia.

Since the brain is the organ least tolerant to oxygen deprivation, use of this monitor can help protect patients against devastating brain injury or other complications that can last a lifetime and take a huge toll financially. Oxygen problems that lead to injury often have no outward signs. They can brew silently over time and go undetected until damage has already been done.

The INVOS® System is unique in that it allows doctors and nurses to measure site-specific oxygen levels, rather than providing a whole-body measure like heart rate, temperature or blood pressure. Place up to four sensors on the exact brain and body areas you want to track. With the INVOS® System, you'll have a continuous, real-time 24/7 watch over your compromised patients through noninvasive, patient-friendly monitoring.

Read more:
The Somanetics Advantage
Evidence-Based Cerebral/Somatic Oximetry
Rewards for Reflecting the Color of Life®

The Somanetics Advantage

Somanetics Corporation is the pioneer and leader of cerebral and somatic (of the body) oximetry, providing U.S. clinicians with the first adult cerebral oximeter, the first pediatric cerebral oximeter and the first simultaneous brain and body oximeter. At Somanetics, noninvasive, site-specific oximetry is our only business, and this commitment and dedication to NIRS technology shows.

The INVOS® System is routinely used and trusted in over 1,200 installs internationally, 700+ U.S. hospitals, and 80% of hospitals performing pediatric cardiac surgery.
  • Appropriate for adult, pediatric, infant and neonatal patients
  • Currently used in cardiac, general and vascular surgery; intensive care units; interventional cardiac catheterization labs; the emergency room; and other settings where the brain and body are at risk of reduced-flow or no-flow ischemic states

Besides offering the only device of its kind, Somanetics has a full-time sales and clinical education team ready to assist you. Fifty-percent have been previously employed as clinical caregivers so you can expect customer service in tune with your needs.

Lastly, we adhere to responsible marketing practices via communications backed by clinical evidence, so you can put your trust in the Somanetics advantage.

Evidence-Based Cerebral/Somatic Oximetry

The INVOS® System, manufactured by Somanetics Corporation (NASDAQ: SMTS), is the clinical reference standard in cerebral/somatic oximetry. With 600+ clinical references, it has demonstrated its value in helping clinicians detect oxygenation issues in adults, children, infants and neonates so that damaging complications can be reduced or prevented altogether.
  • For adults, these include reductions in major organ morbidity or mortality1, stroke2, post-op cognitive declines3, respiratory failure/vent time2, adverse surgical events4 and coma5.
  • For children, infants and neonates, these include enhanced detection of oxygen threats associated with low cardiac output6, renal dysfunction7, neurologic damage8, shock9 and seizures10.
  • Studies1,5 also show that routine interventions taken to rectify ischemic threats are successful 80-94% of the time.
  • Additionally, INVOS® System monitoring often provides an earlier indication of oxygen imbalance than today's traditional patient assessment measures such as mean arterial pressure, pulse oximetry, arterial blood gases and lactates11,7,9.
  • On top of patient benefits, a cost saving analysis study12 showed that there are financial benefits of using cerebral oximetry in the OR. Decreasing the instances of stroke, prolonged ventilation, hospital length of stay, and ICU days, hospitals can optimize their savings.

The 4-channel INVOS® System may be used for cerebral oximetry, somatic oximetry or both simultaneously. Its regional oxygen saturation (rSO2) is a vital sign that helps critical care teams detect and correct blood oxygen changes that can lead to complications and poor outcomes.

Rewards for Reflecting the Color of Life®

On top of the many patient benefits from monitoring with the INVOS® System, clinicians benefit too.
  • Early intervention: In medicine, knowledge is power. Getting an early warning of ischemic threats can be life-saving for your patients. With the INVOS® System, you can detect and correct oxygen imbalances that can lead to harmful complications.
  • Flexible monitoring: A choice of two or four data channels provides cerebral oximetry, somatic oximetry or both simultaneously. The INVOS® System can also be used in tandem with additional neuro monitors.
  • Customized care: Since every patient is unique and serves as his/her own control, the INVOS® System allows you to tailor decisions to the patient's unique physiology and co-morbidities for optimal care.
  • Independent assessment: Gain critical oxygen data on your patients during scenarios where pulse, pressure or temperature may be compromised.
  • Teamwork enhancement: Enable your whole care team - doctors, nurses, anesthesiologists, intensivists and others - to work and communicate more closely to secure good outcomes.

Footnotes:
  1. Murkin JM, et al. Anesth Analg 2007; 104:51-8.
  2. Goldman S, et al. Heart Surg Forum. 2004;7(5):E376-81.
  3. Casati A, et al., Anesth & Analg 2005;101:740.
  4. Gottlieb EA, et al. Ped Anesth 2006; 16:787-9.
  5. Ganzel BL, et al. Presented at the STS Annual Meeting, Jan 2002, Ft. Lauderdale, FL.
  6. Hoffman GM, et al. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2005, pp 12-21.
  7. Hoffman GM, et al. Anesthesiology 2005; 103:A1327.
  8. Dent CL, et al. J Thorac Cardiovasc Surg 2005; 130: 1523-30.
  9. Kaufman et al. J Ped Crit Care Med 2008; 9:62-8.
  10. Diaz GA, et al. Eur J Paediatr Neurol 2006; 10:19-21.
  11. Tobias JD. Anesthesiology 2006; 105: A240.
  12. Default values and performance improvement metrics derived from a financial analysis of "Monitoring Brain Oxygen Saturation During Coronary Bypass Surgery: A Randomized, Prospective Study," John M. Murkin, MD, FRCP, et al. Anesth Analg 2007;104:51-8.
     
    200 OK

    OK

    The server encountered an internal error or misconfiguration and was unable to complete your request.

    Please contact the server administrator, [no address given] and inform them of the time the error occurred, and anything you might have done that may have caused the error.

    More information about this error may be available in the server error log.